Join us as we dive into the latest research with investigator, Dr Vivek Reddy (Mount Sinai Hospital, New York, NY, US), as he discusses the one-year results from the MANIFEST-PF registry, adding insights to the evolving landscape of pulsed-field ablation.The trial studied the use of the Pentaspline PFA Catheter in patients with paroxysmal or persistent atrial fibrillation in order to understand how the device is being used in clinical practice and its outcomes. 24 centers were involved in the trial, with 1500 patients participating.
Questions
What's the evidence on pentaspline PFA catheter?
The MANIFEST-PF study design.
Overview of the MANIFEST-PF cohort.
What are the main findings of MANIFEST-PF?
What are the unknowns and promises of PFA technology?
What are the planned next steps based on MANIFEST-PF findings?
Recorded on-site at EHRA 2023, Barcelona.
Visit Radcliffe Cardiology:
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook:
Follow us on Twitter:
Музыка
Фильмы
ТВ Шоу
Категории видео
